Table 5.
Risk factors of death at day 30 after transjugular kidney biopsy
| Transjugular kidney biopsy | Univariate |
P value | Multivariable |
P value |
|---|---|---|---|---|
| OR, 95%CI | OR, 95%CI | |||
| Major bleeding after biopsy | 2.30 (1.42–4.06) | 0.001 | 1.77 (1.00–3.14) | 0.05 |
| Age (per 1 quartile) | 1.35 (1.13–1.60) | 0.001 | 1.44 (1.16–1.80) | 0.001 |
| Sex (male) | 1.57 (1.05–2.32) | 0.03 | 1.20 (0.78–1.84) | 0.40 |
| Charlson Comorbidity Index (per 1 quartile) | 1.37 (1.15–1.64) | <0.0001 | 0.77 (0.59–1.01) | 0.06 |
| Frailty index (per 1 quartile) | 1.41 (1.18–1.69) | <0.0001 | 1.08 (0.87–1.34) | 0.50 |
| History of cardiovascular and metabolic diseases | ||||
| Hypertension | 0.62 (0.43–0.90) | 0.01 | 0.50 (0.32–0.77) | 0.002 |
| Diabetes mellitus | 0.72 (0.47–1.10) | 0.12 | 0.57 (0.34–0.96) | 0.04 |
| Obesity | 1.22 (0.80–1.85) | 0.36 | 1.63 (1.01–2.62) | 0.05 |
| Heart failure | 2.87 (1.97–4.18) | <0.0001 | 2.71 (1.70–4.33) | <0.0001 |
| Valve disease | 1.36 (0.70–2.62) | 0.36 | 0.74 (0.36–1.53) | 0.42 |
| Coronary artery disease | 1.38 (0.90–2.12) | 0.14 | 0.98 (0.55–1.76) | 0.96 |
| Vascular disease | 1.34 (0.84–2.12) | 0.22 | 1.42 (0.77–2.62) | 0.26 |
| Atrial fibrillation | 2.00 (1.29–3.12) | 0.002 | 1.17 (0.69–2.00) | 0.55 |
| Stroke | 0.63 (0.20–1.99) | 0.43 | 0.66 (0.20–2.21) | 0.50 |
| Smoker | 1.12 (0.65–1.90) | 0.69 | 0.82 (0.46–1.48) | 0.52 |
| Dyslipidemia | 0.65 (0.41–1.02) | 0.06 | 0.72 (0.43–1.22) | 0.22 |
| History of other comorbid conditions | ||||
| Denutrition | 1.80 (1.13–2.86) | 0.01 | 0.98 (0.58–1.64) | 0.93 |
| Alcohol-related disease | 3.31 (2.24–4.89) | <0.0001 | 1.37 (0.80–2.34) | 0.25 |
| Lung disease | 1.58 (1.00–2.49) | 0.05 | 1.04 (0.63–1.74) | 0.87 |
| Liver disease | 4.61 (3.19–6.65) | <0.0001 | 4.25 (2.54–7.13) | <0.0001 |
| Anaemia | 1.45 (1.00–2.09) | 0.05 | 0.84 (0.55–1.31) | 0.45 |
| Thrombocytopenia | 1.31 (0.80–2.16) | 0.28 | 0.63 (0.36–1.09) | 0.10 |
| History of cancer | 2.09 (1.44–3.01) | <0.0001 | 1.97 (1.23–3.07) | 0.003 |
| Renal presentations | ||||
| Abnormal renal function | 0.70 (0.48–1.02) | 0.06 | 0.65 (0.43–1.00) | 0.05 |
| Acute renal injury | 4.53 (2.90–7.06) | <0.0001 | 3.39 (2.05–5.61) | <0.0001 |
| Glomerular disease | 0.57 (0.37–0.89) | 0.01 | 1.01 (0.62–1.63) | 0.97 |
| Vascular or hypertensive disease | 0.40 (0.16–0.99) | 0.05 | 0.64 (0.25–1.67) | 0.36 |
| Diabetic kidney disease | 0.49 (0.20–1.19) | 0.12 | 0.63 (0.23–1.72) | 0.37 |
| Autoimmune disease | 0.47 (0.20–1.06) | 0.07 | 0.89 (0.37–2.15) | 0.80 |
| Vasculitis | 0.35 (0.05–2.54) | 0.30 | 0.30 (0.04–2.26) | 0.24 |
| Hematological-related renal disease | 0.39 (0.05–2.83) | 0.35 | 0.33 (0.04–2.46) | 0.28 |
| Thrombotic microangiopathy | 0.89 (0.36–2.18) | 0.79 | 1.13 (0.43–2.96) | 0.80 |
| Amyloidosis | 4.16 (1.47–11.78) | 0.007 | 2.95 (0.98–8.87) | 0.06 |
| Other diagnoses | 0.79 (0.11–5.76) | 0.82 | 0.78 (0.10–5.99) | 0.81 |
CI, confidence interval; OR, odds ratio.